Reply To: Traders Market Weekly: The Fed, BoE and SNB and a Leaky Dyke…

#55056
Truman
Participant

Sarepta Therapeutics (SRPT 123.98, -25.69, -17.2%): moving lower after FDA determines that an advisory committee meeting will be held for SRP-9001